300 related articles for article (PubMed ID: 35355615)
41. Targeted hepatitis E vaccination for women of childbearing age is cost-effective in China.
Xia R; Sun S; Shen M; Zhang L; Zhuang G
Vaccine; 2019 Sep; 37(39):5868-5876. PubMed ID: 31443991
[TBL] [Abstract][Full Text] [Related]
42. Cost-effectiveness analysis of hepatitis E vaccination strategies among patients with chronic hepatitis B in China.
Cui T; Zhang X; Wang Q; Yue N; Bao C; Jiang R; Xu S; Yuan Z; Qian Y; Chen L; Hang H; Zhang Z; Sun H; Jin H
Hepatol Res; 2024 Feb; 54(2):142-150. PubMed ID: 37706554
[TBL] [Abstract][Full Text] [Related]
43. Decision tree-Markov model of perinatal depression screening: a cost-utility analysis.
Yang Y; Zheng R; Yang L; Huang X; Zhang T
Front Public Health; 2024; 12():1308867. PubMed ID: 38832225
[TBL] [Abstract][Full Text] [Related]
44. Satisfaction of patients and primary care professionals with a teleophthalmology-based screening programme for diabetic retinopathy in a rural area in Castilla y León, Spain.
Valpuesta Martin Y; Pacheco Callirgos GE; Maroto Martín TM; Piriz Veloso M; Hernández Santamaría S; López Gálvez MI
Rural Remote Health; 2020 Jan; 20(1):5180. PubMed ID: 31941342
[TBL] [Abstract][Full Text] [Related]
45. Economic evaluation of cervical cancer screening strategies in urban China.
Ma L; Wang Y; Gao X; Dai Y; Zhang Y; Wang Z; Wang X; Wang L; Jiang J; Jing X; Yang C; Zhao F; Lang J; Qiao Y
Chin J Cancer Res; 2019 Dec; 31(6):974-983. PubMed ID: 31949399
[TBL] [Abstract][Full Text] [Related]
46. Effect of vaccination age on cost-effectiveness of human papillomavirus vaccination against cervical cancer in China.
Liu YJ; Zhang Q; Hu SY; Zhao FH
BMC Cancer; 2016 Feb; 16():164. PubMed ID: 26919850
[TBL] [Abstract][Full Text] [Related]
47. Cost-effectiveness analysis of ranibizumab for retinal vein occlusion patients in China from the societal perspective.
Ni W; Liu J; Jiang Y; Wu J
BMC Ophthalmol; 2021 May; 21(1):229. PubMed ID: 34024275
[TBL] [Abstract][Full Text] [Related]
48. [Effectiveness of different screening strategies for primary prevention of cardiovascular diseases in a rural northern Chinese population].
Si YQ; Tang X; Zhang DD; He L; Cao Y; Wang JW; Li N; Liu JJ; Gao P; Hu YH
Beijing Da Xue Xue Bao Yi Xue Ban; 2018 Jun; 50(3):443-449. PubMed ID: 29930411
[TBL] [Abstract][Full Text] [Related]
49. Cost-effectiveness of a community-based cardiovascular disease prevention intervention in medically underserved rural areas.
Wang H; Kenkel D; Graham ML; Paul LC; Folta SC; Nelson ME; Strogatz D; Seguin RA
BMC Health Serv Res; 2019 May; 19(1):315. PubMed ID: 31096977
[TBL] [Abstract][Full Text] [Related]
50. Urban diabetic retinopathy teleophthalmology screening: results and impact at the service corridor.
Boucher MC; El Yamani MEM
Can J Ophthalmol; 2019 Jun; 54(3):359-366. PubMed ID: 31109477
[TBL] [Abstract][Full Text] [Related]
51. Cost-effectiveness of new antiviral treatments for non-genotype 1 hepatitis C virus infection in China: a societal perspective.
Wei X; Zhao J; Yang L
BMJ Glob Health; 2020 Nov; 5(11):. PubMed ID: 33246983
[TBL] [Abstract][Full Text] [Related]
52. Cost-Utility Analysis of Wide-Field Imaging as an Auxiliary Technology for Retinopathy of Prematurity Care in Brazil.
Neves LM; Haefeli LM; Zin AA; Steffen RE; Vasconcelos ZFM; Pinto M
Front Pediatr; 2021; 9():757258. PubMed ID: 34976892
[No Abstract] [Full Text] [Related]
53. Cost Utility of Supporting Family-Based Care to Prevent HIV and Deaths among Orphaned and Separated Children in East Africa: A Markov Model-Based Simulation.
Wilson-Barthes M; Braitstein P; DeLong A; Ayuku D; Atwoli L; Sang E; Galárraga O
MDM Policy Pract; 2022; 7(2):23814683221143782. PubMed ID: 36601384
[TBL] [Abstract][Full Text] [Related]
54. The clinical effectiveness and cost-effectiveness of cardiac resynchronisation (biventricular pacing) for heart failure: systematic review and economic model.
Fox M; Mealing S; Anderson R; Dean J; Stein K; Price A; Taylor RS
Health Technol Assess; 2007 Nov; 11(47):iii-iv, ix-248. PubMed ID: 17999842
[TBL] [Abstract][Full Text] [Related]
55. Universal screening for HCV infection in China: An effectiveness and cost-effectiveness analysis.
Zhou H; Yan M; Che D; Wu B
JHEP Rep; 2024 Apr; 6(4):101000. PubMed ID: 38481389
[TBL] [Abstract][Full Text] [Related]
56. Estimated Cost-effectiveness of Newborn Screening for Congenital Cytomegalovirus Infection in China Using a Markov Model.
Chen K; Zhong Y; Gu Y; Sharma R; Li M; Zhou J; Wu Y; Gao Y; Qin G
JAMA Netw Open; 2020 Dec; 3(12):e2023949. PubMed ID: 33275150
[TBL] [Abstract][Full Text] [Related]
57. Implementing an influenza vaccination programme for adults aged ≥65 years in Poland: a cost-effectiveness analysis.
Brydak L; Roiz J; Faivre P; Reygrobellet C
Clin Drug Investig; 2012 Feb; 32(2):73-85. PubMed ID: 22201294
[TBL] [Abstract][Full Text] [Related]
58. Cost-Effectiveness of Care Environments for Improving the Mental Health of Orphaned and Separated Children and Adolescents in Kenya.
Wilson-Barthes M; Chrysanthopoulou SA; Atwoli L; Ayuku D; Braitstein P; Galárraga O
J Ment Health Policy Econ; 2021 Jun; 24(2):31-41. PubMed ID: 34151779
[TBL] [Abstract][Full Text] [Related]
59. The effectiveness and cost-effectiveness of carmustine implants and temozolomide for the treatment of newly diagnosed high-grade glioma: a systematic review and economic evaluation.
Garside R; Pitt M; Anderson R; Rogers G; Dyer M; Mealing S; Somerville M; Price A; Stein K
Health Technol Assess; 2007 Nov; 11(45):iii-iv, ix-221. PubMed ID: 17999840
[TBL] [Abstract][Full Text] [Related]
60. Surveillance of Barrett's oesophagus: exploring the uncertainty through systematic review, expert workshop and economic modelling.
Garside R; Pitt M; Somerville M; Stein K; Price A; Gilbert N
Health Technol Assess; 2006 Mar; 10(8):1-142, iii-iv. PubMed ID: 16545207
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
